UltraSPECT is a company specializing in nuclear medicine imaging. It utilizes a Wide-Beam Reconstruction (WBR) technology aiming to lower radiopharmaceutical doses, shorten acquisition times, and increase imaging resolutions. The company provides Xpress.Cardiac technology that uses half the radiopharmaceutical dose or half the scan time and Xpress3.Cardiac technology that offers reduced-dose and reduced-time imaging.